-
Je něco špatně v tomto záznamu ?
Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release
A. Franc, D. Sabadková, D. Neumann, S. Pavloková, P. Kopecká, J. Muselík,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
NT14479
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Medline Complete (EBSCOhost)
od 1999-01-01 do Před 1 rokem
- MeSH
- celulosa analogy a deriváty chemie MeSH
- diabetes mellitus farmakoterapie MeSH
- dítě MeSH
- farmaceutická chemie metody MeSH
- glukosa aplikace a dávkování MeSH
- hypoglykemie farmakoterapie MeSH
- hypoglykemika aplikace a dávkování MeSH
- implantované léky aplikace a dávkování MeSH
- lékové formy MeSH
- lékové transportní systémy metody MeSH
- léky s prodlouženým účinkem aplikace a dávkování chemie MeSH
- lidé MeSH
- polyethylenglykoly chemie MeSH
- pomocné látky chemie MeSH
- rozpustnost MeSH
- škrob analogy a deriváty chemie MeSH
- velikost částic MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Patients tend to evade the occurrence of hypoglycemic episodes by excessive carbohydrate intake. Glucose pellets with delayed release in the time of the maximum effect of insulin can not only prevent hypoglycemia but also eliminate the preventive carbohydrate intake. The pellets can be administered in a mixture with semisolid food. The cores containing glucose in combination with osmotically active agents (croscarmellose sodium, carmellose sodium, polyethylene glycol, or carboxymethyl starch) were prepared by extrusion-spheronization and coated with 15% water ethylcellulose dispersion (Surelease® B NF) in Wurster column (Medipo, Havlíčkův Brod, Czech Republic) into four coating levels (12.5, 25, 35, and 50%). Mean particle size is 0.63-0.73 for cores and 0.82-0.98 for coated pellets. Cores and coated pellets have excellent or good flow properties according to Hausner ratio and Carr index. Aspect ratio ranges from 1.78 to 2.17 for cores and from 1.73 to 2.31 for coated pellets. Dissolution was performed using pH-independent method and method with continual change of pH. The suitable pH-independent release was achieved in the samples containing carboxymethyl starch or polyethylene glycol. Glucose release is enabled by a membrane rupture caused by core swelling. It can be, therefore, assumed that the glucose release profile will not be affected by food or transit time.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014261
- 003
- CZ-PrNML
- 005
- 20190517105114.0
- 007
- ta
- 008
- 170413s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/10837450.2015.1073741 $2 doi
- 035 __
- $a (PubMed)26334252
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Franc, Aleš, $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $d 1968- $7 mzk2008479726
- 245 10
- $a Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release / $c A. Franc, D. Sabadková, D. Neumann, S. Pavloková, P. Kopecká, J. Muselík,
- 520 9_
- $a Patients tend to evade the occurrence of hypoglycemic episodes by excessive carbohydrate intake. Glucose pellets with delayed release in the time of the maximum effect of insulin can not only prevent hypoglycemia but also eliminate the preventive carbohydrate intake. The pellets can be administered in a mixture with semisolid food. The cores containing glucose in combination with osmotically active agents (croscarmellose sodium, carmellose sodium, polyethylene glycol, or carboxymethyl starch) were prepared by extrusion-spheronization and coated with 15% water ethylcellulose dispersion (Surelease® B NF) in Wurster column (Medipo, Havlíčkův Brod, Czech Republic) into four coating levels (12.5, 25, 35, and 50%). Mean particle size is 0.63-0.73 for cores and 0.82-0.98 for coated pellets. Cores and coated pellets have excellent or good flow properties according to Hausner ratio and Carr index. Aspect ratio ranges from 1.78 to 2.17 for cores and from 1.73 to 2.31 for coated pellets. Dissolution was performed using pH-independent method and method with continual change of pH. The suitable pH-independent release was achieved in the samples containing carboxymethyl starch or polyethylene glycol. Glucose release is enabled by a membrane rupture caused by core swelling. It can be, therefore, assumed that the glucose release profile will not be affected by food or transit time.
- 650 _2
- $a celulosa $x analogy a deriváty $x chemie $7 D002482
- 650 _2
- $a farmaceutická chemie $x metody $7 D002626
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a léky s prodlouženým účinkem $x aplikace a dávkování $x chemie $7 D003692
- 650 _2
- $a diabetes mellitus $x farmakoterapie $7 D003920
- 650 _2
- $a lékové formy $7 D004304
- 650 _2
- $a lékové transportní systémy $x metody $7 D016503
- 650 _2
- $a implantované léky $x aplikace a dávkování $7 D004343
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a glukosa $x aplikace a dávkování $7 D005947
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemie $x farmakoterapie $7 D007003
- 650 _2
- $a hypoglykemika $x aplikace a dávkování $7 D007004
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a polyethylenglykoly $x chemie $7 D011092
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a škrob $x analogy a deriváty $x chemie $7 D013213
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sabadková, Dana $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 _AN080394
- 700 1_
- $a Neumann, David, $u Department of Pediatrics , University Hospital , Hradec Králové , Czech Republic. $d 1973- $7 xx0079752
- 700 1_
- $a Pavloková, Sylvie $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 xx0238422
- 700 1_
- $a Kopecká, Pavlína $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 _AN087079
- 700 1_
- $a Muselík, Jan $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 xx0100243
- 773 0_
- $w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 21, č. 7 (2016), s. 867-874
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26334252 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20190517105223 $b ABA008
- 999 __
- $a ok $b bmc $g 1200726 $s 975039
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 21 $c 7 $d 867-874 $e 20150831 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
- GRA __
- $a NT14479 $p MZ0
- LZP __
- $a Pubmed-20170413